C
CANDEL THERAPEUTICS INC
NASDAQ: CADL (Candel Therapeutics, Inc.)
Last update: 4 hours ago13.13
0.78 (6.32%)
| Previous Close | 12.35 |
| Open | 12.65 |
| Volume | 1,335,277 |
| Avg. Volume (3M) | 1,655,411 |
| Market Cap | 1,004,688,832 |
| Price / Sales | 436.42 |
| Price / Book | 7.37 |
| 52 Weeks Range | |
| Earnings Date | 12 Nov 2026 |
| Diluted EPS (TTM) | -1.33 |
| Total Debt/Equity (MRQ) | 14.61% |
| Current Ratio (MRQ) | 4.64 |
| Operating Cash Flow (TTM) | -27.20 M |
| Levered Free Cash Flow (TTM) | -8.33 M |
| Return on Assets (TTM) | -32.31% |
| Return on Equity (TTM) | -98.14% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Candel Therapeutics, Inc. | Mixed | Bearish |
AIStockmoo Score
-0.5
| Analyst Consensus | NA |
| Insider Activity | -3.0 |
| Price Volatility | -3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | -0.50 |
|
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 17.53% |
| % Held by Institutions | 40.72% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Halter Ferguson Financial Inc. | 30 Jun 2026 | 772,461 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| TYAGARAJAN SESHU | - | 12.16 | -7,000 | -85,120 |
| Aggregate Net Quantity | -7,000 | |||
| Aggregate Net Value ($) | -85,120 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 12.16 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| TYAGARAJAN SESHU | Officer | 17 Aug 2026 | Automatic sell (-) | 7,000 | 12.16 | 85,120 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |